| Followers | 461 |
| Posts | 37019 |
| Boards Moderated | 0 |
| Alias Born | 01/11/2004 |
Saturday, August 01, 2020 12:50:42 PM
$RVVTF - GREEN LIGHT!!! - the Company did not have to perform any Phase 1 or Phase 2 clinical studies.
http://www.baystreet.ca/articles/stockstowatch/57630/Psychedelics-Revolution-Creating-a-Multi-Billion-Dollar-Investment-Opportunity
http://www.baystreet.ca/articles/stockstowatch/57630/Psychedelics-Revolution-Creating-a-Multi-Billion-Dollar-Investment-Opportunity
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
